Recombinant EGFR (Nimotuzumab Biosimilar) 抗体
This Human 单克隆 antibody specifically detects EGFR (Nimotuzumab Biosimilar) in FACS, BR 和 IHC. It exhibits reactivity toward 人.
产品编号 ABIN7072381
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant EGFR (Nimotuzumab Biosimilar) 抗体 (ABIN7072381)
抗原
EGFR (Nimotuzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This EGFR (Nimotuzumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), Blocking Reagent (BR), Immunohistochemistry (IHC)
克隆位点
H-R3
-
-
原理
- Anti-EGFR domain III [h-R3 (Nimotuzumab)], Human IgG1, kappa
-
特异性
- Binds to human EGFR domain III at a site distinct from antibody 7A7 (Ab00134) (Talavera et al. 2011)
-
产品特性
-
Original Species of Ab: Human
Original Format of Ab: IgG1
-
纯化方法
- Protein A affinity purified
-
免疫原
- This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
-
亚型
- IgG1 kappa
-
-
-
-
应用备注
- This antibody binds to human EGFR and inhibits EGF-dependent clonogenic growth of NRK cells and completely blocks EGF stimulated autophosphorylation of the receptor (Fernandez 1992)
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 0.02 % Proclin 300.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- EGFR (Nimotuzumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- ERBB-D3, ERBB1, HER1, PIG61, mENA, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1, epidermal growth factor
-
UniProt
- P00533
抗原
-
You are here:
